We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Bryostatin-1

News List

BryoLogyx Completes World’s First GMP Synthesis of Bryostatin-1 contractpharma
October 15, 2020
BryoLogyx has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing Practice (GMP) regulations.
BryoLogyx Acquires Rights to Neurotrope’s Bryostatin-1 contractpharma
June 16, 2020
Bryostatin-1 will be chemically synthesized by Albany Molecular Research Inc. (AMRI) in collaboration with BryoLogyx.
Bryostatin-1 Study Does Not Meet Primary Endpoint americanpharmaceuticalreview
September 10, 2019
Neurotrope announced its confirmatory Phase 2 study of Bryostatin-1 in moderate to severe AD did not achieve statistical significance on the primary endpoint...
Neurotrope Announces Agreement for Bryostatin-1 with National Cancer Institute americanpharmaceuticalreview
February 19, 2019
Neurotrope has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the research and clinical development of Bryostatin-1.....